Specify a stock or a cryptocurrency in the search bar to get a summary
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
603392Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. researches, develops, produces, distributes, and sells infectious disease diagnostic reagents and vaccines in China and internationally. The company provides COVID 19, HIV and HTLV, Hepatitis, EV-71, and Tuberculosis diagnostics test kits; Hepatitis C and Syphilis detection reagents; automated immunoassays; ELISA kits and rapid tests for infectious disease diagnostics; chemiluminescence and clinical chemistry reagents; immunodiagnostic reagents; and Hepatitis E and human papillomavirus vaccines. It serves blood banks, hospitals and clinics, reference laboratories, border inspection centers, blood-processing companies, and research institutes. The company was founded in 1991 and is headquartered in Beijing, China. Address: No. 31 Science Park Road, Beijing, China, 102206
Analytics
WallStreet Target Price
465.91 CNYP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 603392
Dividend Analytics 603392
Dividend growth over 5 years
–Continuous growth
2 yearsPayout Ratio 5 years average
36 %Dividend History 603392
Stock Valuation 603392
Financials 603392
Results | 2019 | Dynamics |